Armata Pharmaceuticals (ARMP) Q4 2024 Earnings

13NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.69
-0.51
-0.33
-0.15

Details

Expected EPS
-0.28
Actual EPS
-0.15
Surprise EPS
0.13
Surprise Percent
+46.43%

Description

Armata Pharmaceuticals (ARMP) has reported earnings of -0.15 per share for Q4 2024.

0 Comments

Share your thoughts